How To Earn $500 A Month From Alphabet Stock Ahead Of Q2 Earnings
Analysts expect the Mountain View, California-based company to report quarterly earnings at $2.17 per share, compared to $1.89 per share in the year-ago period. Alphabet projects to report quarterly revenue of $93.72 billion, compared to $84.74 billion a year earlier, according to data from Benzinga Pro.
The Google parent company has beaten analyst estimates for revenue in 10 straight quarters. It has also beaten analyst estimates for earnings per share in nine straight quarters.
With the recent buzz around Alphabet, some investors may be eyeing potential gains from the company's dividends. As of now, Alphabet offers an annual dividend yield of 0.44%, which is a semi-annual dividend amount of 21 cents per share (84 cents a year).
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $1,366,742 or around 7,143 shares. For a more modest $100 per month or $1,200 per year, you would need $273,425 or around 1,429 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($0.84 in this case). So, $6,000 / $0.84 = 7,143 ($500 per month), and $1,200 / $0.84 = 1,429 shares ($100 per month).
View more earnings on GOOGL
Note that the dividend yield can change on a rolling basis, as both the dividend payment and the stock price fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock's current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
GOOGL Price Action: Shares of Alphabet gained 0.7% to close at $191.34 on Tuesday.Read More: Image: Shutterstock
Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
ALPHABET (GOOGL): Free Stock Analysis Report
ALPHABET (GOOG): Free Stock Analysis Report
This article How To Earn $500 A Month From Alphabet Stock Ahead Of Q2 Earnings originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
14 minutes ago
- Yahoo
International Flavors and Fragrances beats quarterly revenue, profit estimates
(Reuters) -International Flavors and Fragrances topped Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by resilient demand, higher prices and a shift to better-margin businesses. The company has streamlined its portfolio as choppy demand in some food and beauty markets forced its customers to hold leaner inventories. On Tuesday, the company, which disposed of its pharma solutions business earlier this year, said it would sell its soy crush, concentrates, and lecithin unit to U.S. grain trader and processor Bunge Global. IFF did not disclose financial terms but said the operations generated about $240 million in revenue in 2024. The company posted net sales of $2.76 billion for the quarter ended June 30, beating estimates of $2.70 billion, according to data compiled by LSEG. Its adjusted profit of $1.15 per share also topped expectations of $1.12. Advance purchases by packaged food and beauty companies looking to beat higher prices due to tariffs also boosted sales at IFF in the reported quarter. "We remain on track to deliver our 2025 commitments we outlined earlier this year, even as the operating environment has become more challenging," said CEO Erik Fyrwald. IFF's shares were up nearly 5% in extended trading. They have fallen about 16% so far this year. The New York-headquartered company maintained its annual sales and adjusted core profit targets. The company also said it authorized a new share buyback program with a total value of $500 million. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Yahoo
Long-Term Unemployment Rises In Worrying Sign For U.S. Labor Market
WASHINGTON – Signals of labor market weakness go beyond the headline numbers that prompted President Donald Trump to fire the government's head statistician last week. The jobs report released Friday showed a slowdown in hiring, a slight uptick in the national unemployment rate, and a few other clues that the economy is softening — including an increase in long-term unemployment. The number of people jobless for six months or more increased from 1.6 million to 1.8 million in July, representing 24% of the unemployed. It's the most people experiencing long-term joblessness since the end of 2021 and the highest percentage since February 2022, when the economy was still recovering from coronavirus lockdowns. Valerie Wilson, a labor economist at the liberal Economic Policy Institute, said the modest rise in long-term joblessness could reflect employers getting pickier about hiring as President Donald Trump's tariff regime changes the cost of doing business. 'People who have been unemployed for longer have clearly had some challenges in getting back into the labor market,' Wilson told HuffPost. 'I think that as things have softened, and employers are facing more uncertainty given the sort of chaotic nature of economic policy in this country, that it would be harder for those people to find new jobs.' The president's tariffs on goods imported from other countries are tantamount to a $1,219 tax increase on American households this year, according to an estimate by the conservative Tax Foundation. HuffPost readers: Dealing with long-term unemployment? Tell us about it – email arthur@ Please include your phone number if you're willing to be interviewed. Persistently high long-term joblessness was a hallmark of slow recovery from the Great Recession that officially ended in 2009. It disproportionately affected older workers, becoming a self-perpetuating problem as employers sought job applicants with minimal or no gaps on their resumes. Some economists worry another recession could be around the corner. The overall unemployment rate remained low in July, at just 4.2%, and the economy has continued to add jobs, albeit at a slower pace than previously estimated. Bureau of Labor Statistics data suggest the last three months were the weakest for job growth since the pandemic. Trump fired the BLS commissioner on Friday, claiming without evidence that the numbers were somehow 'rigged' to make him look bad. The labor force shrank slightly in July, helping hold down the unemployment rate even as the number of employed workers declined. Wilson noted the unemployment rate for Black Americans rose to 7.2%, up from a recent historical low of 4.8% in April 2023. 'Over the last two months, we're seeing the black unemployment rate pick up, which is another one that as that starts to rise, we start to look for signals of a broader slowing in the economy,' Wilson said.
Yahoo
14 minutes ago
- Yahoo
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue other career opportunities. Krumme will report to Chief Financial Officer, Jill McConnell, and lead Fortrea's global investor relations strategy, serving as a key liaison to the investment community. 'Tracy is a seasoned executive with the strategic mindset and investor acumen needed as Fortrea enters its next chapter,' said McConnell. 'She brings not only deep capital markets expertise but also integrity, insight and a strong track record of supporting strategic transformation and growth. We're excited to welcome her to the team. I also would like to express my sincere appreciation to Hima Inguva, who has led Fortrea's Investor Relations since our founding as a company. We wish her every success in her next chapter.' Krumme brings more than three decades of investor relations and capital markets experience to Fortrea, with expertise across the CRO, life sciences and healthcare sectors. She previously served as head of investor relations at PPD, a leading CRO acquired by Thermo Fisher Scientific, where she worked alongside Fortrea's CEO Anshul Thakral; Galderma, a global dermatology company; and Nuance Communications, a provider of healthcare AI solutions acquired by Microsoft. Most recently, she was senior vice president, head of investor relations and corporate communications at Bitfarms, a global energy and compute infrastructure company. Earlier in her career, she led investor relations at Luxoft, acquired by DXC Technology, and NCR Corporation, and held roles as an equity research analyst at Sandler O'Neill & Partners and in corporate finance at Prudential Securities and Kidder, Peabody International in London. 'I'm excited to join Fortrea at such a pivotal moment in its evolution as an independent, pure-play CRO,' said Krumme. 'I look forward to working with the leadership team to articulate Fortrea's vision and value proposition to the investment community as we deliver differentiated solutions to our customers and generate long-term value for shareholders.' About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at and follow us on LinkedIn and X (formerly Twitter). Fortrea Contacts: Tracy Krumme (Investors) – 984-385-6707, Inguva (Investors) – 877-495-0816, Sue Zaranek (Media) – 919-943-5422, media@ Kate Dillon (Media) – 646-818-9115, kdillon@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data